» Articles » PMID: 11313308

Inhibition of the Phosphatidylinositol 3-kinase Pathway Contributes to HT29 and Caco-2 Intestinal Cell Differentiation

Overview
Specialty Gastroenterology
Date 2001 Apr 21
PMID 11313308
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Phosphatidylinositol 3-kinase (PI3K), an important mediator of intracellular signal transduction, has been shown to affect proliferation, differentiation, and apoptosis in a number of cells; the role of PI3K in intestinal cell differentiation is not known.

Methods: The effect of PI3K inhibition on enterocyte-like differentiation of the human colon cancer cells, HT29 and Caco-2, was assessed using complementary approaches (i.e., chemical inhibition with wortmannin, transfection with a dominant negative p85 mutant, or overexpression of the tumor suppressor gene phosphatase and tensin homologue deleted on chromosome 10 [PTEN]). Brush-border enzyme (intestinal alkaline phosphatase [IAP] and sucrase) activities, IAP messenger RNA levels, and IAP promoter induction were measured.

Results: The PI3K inhibitor, wortmannin, in combination with sodium butyrate, synergistically induced IAP and sucrase enzyme activities and IAP messenger RNA levels in a time- and dose-dependent fashion. Consistent with these results, cotransfection using the dominant negative mutant of p85 (Deltap85) induced IAP promoter activity. Moreover, overexpression of PTEN, which antagonizes PI3K, significantly augmented the induction of IAP enzyme activity in HT29 and Caco-2 cells treated with sodium butyrate and in spontaneously differentiated Caco-2 cells.

Conclusions: Our results show that inhibition of PI3K significantly enhances enterocyte-like differentiation of HT29 and Caco-2 cells. Taken together, our findings suggest a contributory role for the PI3K/PTEN pathway in intestinal cell differentiation.

Citing Articles

Vitronectin Destroyed Intestinal Epithelial Cell Differentiation through Activation of PDE4-Mediated Ferroptosis in Inflammatory Bowel Disease.

Pan W, Xiang L, Liang X, Du W, Zhao J, Zhang S Mediators Inflamm. 2023; 2023:6623329.

PMID: 37501933 PMC: 10371469. DOI: 10.1155/2023/6623329.


Lipid Messenger Phosphatidylinositol-4,5-Bisphosphate Is Increased by Both PPARα Activators and Inhibitors: Relevance for Intestinal Cell Differentiation.

Cizkova K, Koubova K, Tauber Z Biology (Basel). 2022; 11(7).

PMID: 36101378 PMC: 9312331. DOI: 10.3390/biology11070997.


DFNA5 inhibits colorectal cancer proliferation by suppressing the mTORC1/2 signaling pathways via upregulation of DEPTOR.

Guo J, Yu J, Mu M, Chen Z, Xu Z, Zhao C Cell Cycle. 2022; 21(20):2165-2178.

PMID: 35923131 PMC: 9518992. DOI: 10.1080/15384101.2022.2088570.


Biochemical and Immunological implications of Lutein and Zeaxanthin.

Zafar J, Aqeel A, Shah F, Ehsan N, Gohar U, Moga M Int J Mol Sci. 2021; 22(20).

PMID: 34681572 PMC: 8535525. DOI: 10.3390/ijms222010910.


ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status.

Bares G, Bea A, Hernandez L, Navaridas R, Felip I, Megino C Cancers (Basel). 2021; 13(15).

PMID: 34359707 PMC: 8345062. DOI: 10.3390/cancers13153803.